FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.5  |  FHIR Version n/a  User: [n/a]

73579000: Carbidopa (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
122178011 Carbidopa en Synonym Active Entire term case insensitive SNOMED CT core module
122179015 MK-486 en Synonym Active Entire term case sensitive SNOMED CT core module
813982014 Carbidopa (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3736797013 Alpha-methyldopa hydrazine en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carbidopa Is a Co-careldopa false Inferred relationship Existential restriction modifier
Carbidopa Is a Antiparkinsonian agent false Inferred relationship Existential restriction modifier
Carbidopa Is a Co-careldopa false Inferred relationship Existential restriction modifier
Carbidopa Is a Dihydroxyphenylalanine true Inferred relationship Existential restriction modifier
Carbidopa Is a Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Carbidopa Has disposition Dopamine receptor agonist true Inferred relationship Existential restriction modifier
Carbidopa Has disposition Dihydroxyphenylalanine decarboxylase inhibitor true Inferred relationship Existential restriction modifier
Carbidopa Is a Chemical categorized functionally false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Co-careldopa 25mg/100mg tablets (Kent Pharma (UK) Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Approved Prescription Services) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg/5ml oral suspension (Special Order) 1 ml Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg/5ml oral suspension 1 ml Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg/5ml oral suspension Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg/5ml oral suspension (Special Order) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Sigma Pharmaceuticals Plc) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Sigma Pharmaceuticals Plc) 50 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Dowelhurst Ltd) 50 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets 100 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Tilolec 100mg/25mg modified-release tablets (Tillomed Laboratories) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (PI) (Waymade Ltd) 100 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Caramet 25mg/100mg CR tablets (Teva UK Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (PI) (Waymade Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets 50 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Tilolec 100mg/25mg modified-release tablets (Tillomed Laboratories) 60 tablet 6 x 10 tablets Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Doncaster Pharmaceuticals Ltd) 60 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (PI) (Waymade Ltd) 50 tablet 5 x 10 tablets Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (PI) (Dowelhurst Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (PI) (Dowelhurst Ltd) 100 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets 60 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Carbidopa + levodopa 25mg/100mg m/r tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Caramet 25mg/100mg CR tablets (Teva UK Ltd) 60 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Doncaster Pharmaceuticals Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg/5ml oral suspension (Special Order) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg/5ml oral suspension (Special Order) 1 ml Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg/5ml oral suspension Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg/5ml oral suspension 1 ml Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Duodopa intestinal gel 100ml cassette (Solvay Healthcare Ltd) 1 bag Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Duodopa intestinal gel cassette 100ml (Solvay Healthcare Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette 1 bag Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette 7 bag Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Duodopa intestinal gel cassette 100ml (Solvay Healthcare Ltd) 1 bag Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg/5ml oral solution (Special Order) 1 ml Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg/5ml oral solution (Special Order) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg/5ml oral solution Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg/5ml oral solution 1 ml Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Carbidopa + levodopa 50mg/200mg m/r tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Tilolec 200mg/50mg modified-release tablets (Tillomed Laboratories) 60 tablet 6 x 10 tablets Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets 60 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet CR 50mg/200mg tablets (PI) (Waymade Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet CR 50mg/200mg tablets (PI) (Waymade Ltd) 60 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet CR 50mg/200mg tablets (PI) (Dowelhurst Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet CR 50mg/200mg tablets (PI) (Dowelhurst Ltd) 60 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet CR 50mg/200mg tablets (Doncaster Pharmaceuticals Ltd) 60 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet CR 50mg/200mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet CR 50mg/200mg tablets (Doncaster Pharmaceuticals Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet CR 50mg/200mg tablets (PI) (Dowelhurst Ltd) 30 tablet 3 x 10 tablets Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet CR 50mg/200mg tablets (PI) (Waymade Ltd) 30 tablet 3 x 10 tablets Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Unichem Plc) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Unichem Plc) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Tilolec 200mg/50mg modified-release tablets (Tillomed Laboratories) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet CR 50mg/200mg tablets (Organon Pharma (UK) Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets 30 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Lexon (UK) Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Lexon (UK) Ltd) 60 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet 110 tablets (Lexon (UK) Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet 275 tablets (Lexon (UK) Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (Lexon (UK) Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet 110 tablets (Lexon (UK) Ltd) 100 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet 275 tablets (Lexon (UK) Ltd) 90 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (Lexon (UK) Ltd) 100 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (A A H Pharmaceuticals Ltd) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (A A H Pharmaceuticals Ltd) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (A A H Pharmaceuticals Ltd) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (A A H Pharmaceuticals Ltd) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Stephar (U.K.) Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (Stephar (U.K.) Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Stephar (U.K.) Ltd) 50 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (Stephar (U.K.) Ltd) 100 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet 10mg/100mg tablets (Mawdsley-Brooks & Company Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Mawdsley-Brooks & Company Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet CR 50mg/200mg tablets (Mawdsley-Brooks & Company Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (Mawdsley-Brooks & Company Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets 50 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet 10mg/100mg tablets (Mawdsley-Brooks & Company Ltd) 100 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Mawdsley-Brooks & Company Ltd) 50 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet CR 50mg/200mg tablets (Mawdsley-Brooks & Company Ltd) 50 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet CR 50mg/200mg tablets (Mawdsley-Brooks & Company Ltd) 60 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (Mawdsley-Brooks & Company Ltd) 100 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (Sigma Pharmaceuticals Plc) 90 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet 10mg/100mg tablets (Necessity Supplies Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Necessity Supplies Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet CR 50mg/200mg tablets (Necessity Supplies Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (Necessity Supplies Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Necessity Supplies Ltd) 100 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet CR 50mg/200mg tablets (Necessity Supplies Ltd) 30 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (Necessity Supplies Ltd) 100 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Mawdsley-Brooks & Company Ltd) 90 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet 10mg/100mg tablets (Necessity Supplies Ltd) 100 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Necessity Supplies Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Necessity Supplies Ltd) 50 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Doncaster Pharmaceuticals Ltd) 50 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (Organon Pharma (UK) Ltd) 100 tablet 10 x 10 tablets Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) 100 tablet 10 x 10 tablets Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet 10mg/100mg tablets (Organon Pharma (UK) Ltd) 100 tablet 10 x 10 tablets Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier

Start Previous Page 11 of 13 Next End


This concept is not in any reference sets

Back to Start